摘要
<正>再次肝移植是挽救不可逆移植肝功能衰竭的唯一有效手段。自第一例肝移植手术成功实施以来,再次肝移植一直是移植医生面临的一项重要挑战。我国肝移植事业经历了20多年的蓬勃快速发展,肝移植手术例数逐年增加,目前已跃居全球第二位。尽管免疫抑制剂的进步显著延长了移植物和患者的生存时间,但接受首次肝移植的患者仍有可能发生移植肝功能衰竭而需要再次肝移植。欧美国家再次肝移植占总移植例数的10%~20%[1-3],其手术和临床处置复杂,技术难度大,患者病情与首次肝移植相比更严重,另外还存在免疫抑制状态导致的高
引文
[1]Moon HH,Kim TS,Song S,et al.Early Vs late liver retransplantation:different characteristics and prognostic factors[J].Transplant Proc,2018,50(9):2668-2674.
[2]Zarrinpar A,Hong JC.What is the prognosis after retransplantation of the liver[J].Adv Surg,2012,46:87-100.
[3]Pfitzmann R,Benscheidt B,Langrehr JM,et al.Trends and experiences in liver retransplantation over 15 years[J].Liver Transpl,2007,13(2):248-257.
[4]Masior?,Gr?t M,Krasnod?bski M,et al.Prognostic factors and outcomes of patients after liver retransplantation[J].Transplant Proc,2016,48(5):1717-1720.
[5]Kamei H,Al-Basheer M,Shum J,et al.Comparison of short-and long-term outcomes after early versus late liver retransplantation:a single-center experience[J].J Surg Res,2013,185(2):877-882.
[6]Yoo PS,Umman V,Rodriguez-Davalos MI,et al.Retransplantation of the liver:review of current literature for decision making and technical considerations[J].Transplant Proc,2013,45(3):854-859.
[7]朱志军,张海明,沈中阳,等.再次肝移植的原因与预后分析[J].中国普外基础与临床杂志,2013,20(3):235-240.
[8]臧运金,吴凤东,沈中阳.提高再次肝脏移植手术成功率的关键技术[J].中国普外基础与临床杂志,2013,20(3):241-245.
[9]傅斌生,张彤,李华,等.再次肝移植的适应证与死亡原因分析[J].器官移植,2011,2(6):320-323.
[10]韩秋成,王正昕,倪之嘉,等.再次肝移植28例经验总结[J].中华肝胆外科杂志,2010,16(10):748-750.
[11]金磊,殷浩,傅宏,等.再次肝移植38例经验[J].中华普通外科杂志,2015,30(7):532-534.
[12]Flemming JA,Kim WR,Brosgart CL,et al.Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy[J].Hepatology,2017,65(3):804-812.
[13]Adam R,Karam V,Cailliez V,et al.2018 Annual Report of the European Liver Transplant Registry(ELTR)-50-year evolution of liver transplantation[J].Transpl Int,2018,31(12):1293-1317.
[14]Zimmerman MA,Ghobrial RM.When shouldn't we retransplant[J].Liver Transpl,2005,(11 Suppl 2):S14-S20.
[15]Kim H,Lee KW,Yi NJ,et al.Outcome and technical aspects of liver retransplantation:analysis of 25-year experience in a single major center[J].Transplant Proc,2015,47(3):727-729.
[16]Abdelfattah MR,Al-Sebayel M,Broering D.An analysis of outcomes of liver retransplant in adults:12-year's single-center experience[J].Exp Clin Transplant,2015,13(Suppl 1):95-99.
[17]Henson JB,Patel YA,King LY,et al.Outcomes of liver retransplantation in patients with primary sclerosing cholangitis[J].Liver Transpl,2017,23(6):769-780.
[18]Memeo R,Laurenzi A,Pittau G,et al.Repeat liver retransplantation:rationale and outcomes[J].Clin Transplant,2016,30(3):312-319.
[19]Crivellin C,De Martin E,Germani G,et al.Risk factors in liver retransplantation:a single-center experience[J].Transplant Proc,2011,43(4):1110-1113.
[20]Watt KD,Lyden ER,McCashland TM.Poor survival after liver retransplantation:is hepatitis C to blame[J].Liver Transpl,2003,9(10):1019-1024.
[21]Torres-Quevedo R,Moya-Herraiz A,San JF,et al.Indications and results of liver retransplantation:experience with 1181 patients at the University Hospital La Fe[J].Cir Esp,2010,87(6):356-363.(收稿日期:2019-01-30)